The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

Modern Healthcare reports that the move by group's health insurance unit will affect members of certain health plans in Colorado, Florida, Illinois, Missouri, North Carolina, Tennessee, Texas, and ...

Cigna is joining the chorus of health insurance companies detailing where they will scale back Medicare Advantage offerings ...

Shares of Cigna Group CI slid 0.24% to $355.39 Wednesday, on what proved to be an all-around poor trading session for the ...

Cigna Group (CI) stock saw a decline, ending the day at $356.23 which represents a decrease of $-10.62 or -2.89% from the prior close of $366.85. The stock opened at $364.66 and touched a low of $354.

The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...

The insurance giant is demanding the retraction of a recent FTC report on pharmacy-benefit managers, calling it "unsupported ...

The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other ...